255 related articles for article (PubMed ID: 19738056)
1. A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors.
Torchia EC; Chen Y; Sheng H; Katayama H; Fitzpatrick J; Brinkley WR; Caulin C; Sen S; Roop DR
Cancer Res; 2009 Sep; 69(18):7207-15. PubMed ID: 19738056
[TBL] [Abstract][Full Text] [Related]
2. Functional roles of Akt signaling in mouse skin tumorigenesis.
Segrelles C; Ruiz S; Perez P; Murga C; Santos M; Budunova IV; MartÃnez J; Larcher F; Slaga TJ; Gutkind JS; Jorcano JL; Paramio JM
Oncogene; 2002 Jan; 21(1):53-64. PubMed ID: 11791176
[TBL] [Abstract][Full Text] [Related]
3. Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma.
Torchia EC; Caulin C; Acin S; Terzian T; Kubick BJ; Box NF; Roop DR
Oncogene; 2012 May; 31(21):2680-90. PubMed ID: 21963848
[TBL] [Abstract][Full Text] [Related]
4. Early epidermal destruction with subsequent epidermal hyperplasia is a unique feature of the papilloma-independent squamous cell carcinoma phenotype in PKCepsilon overexpressing transgenic mice.
Li Y; Wheeler DL; Alters W; Chaiswing L; Verma AK; Oberley TD
Toxicol Pathol; 2005; 33(6):684-94. PubMed ID: 16243773
[TBL] [Abstract][Full Text] [Related]
5. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas.
Park E; Zhu F; Liu B; Xia X; Shen J; Bustos T; Fischer SM; Hu Y
Cancer Res; 2007 Oct; 67(19):9158-68. PubMed ID: 17909021
[TBL] [Abstract][Full Text] [Related]
6. Differential tumor biology effects of double-initiation in a mouse skin chemical carcinogenesis model comparing wild type versus protein kinase Cepsilon overexpression mice.
Li Y; Wheeler DL; Ananthaswamy HN; Verma AK; Oberley TD
Toxicol Pathol; 2007 Dec; 35(7):942-51. PubMed ID: 18098040
[TBL] [Abstract][Full Text] [Related]
7. Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFbetaRII.
Go C; He W; Zhong L; Li P; Huang J; Brinkley BR; Wang XJ
Oncogene; 2000 Jul; 19(32):3623-31. PubMed ID: 10951568
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
9. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
10. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
12. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
Owens DM; Watt FM
Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
[TBL] [Abstract][Full Text] [Related]
13. PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis.
Chen L; Hayden MS; Gilmore ES; Alexander-Savino C; Oleksyn D; Gillespie K; Zhao J; Poligone B
Carcinogenesis; 2018 Mar; 39(3):418-428. PubMed ID: 29186361
[TBL] [Abstract][Full Text] [Related]
14. Malignant conversion, the first stage in progression, is distinct from phorbol ester promotion in mouse skin.
Hennings H
Basic Life Sci; 1991; 57():31-9; discussion 39-42. PubMed ID: 1814291
[TBL] [Abstract][Full Text] [Related]
15. A multihit, multistage model of chemical carcinogenesis.
Owens DM; Wei S; Smart RC
Carcinogenesis; 1999 Sep; 20(9):1837-44. PubMed ID: 10469632
[TBL] [Abstract][Full Text] [Related]
16. Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression.
Ostrowski LE; Finch J; Krieg P; Matrisian L; Patskan G; O'Connell JF; Phillips J; Slaga TJ; Breathnach R; Bowden GT
Mol Carcinog; 1988; 1(1):13-9. PubMed ID: 3151258
[TBL] [Abstract][Full Text] [Related]
17. PAD2 overexpression in transgenic mice augments malignancy and tumor-associated inflammation in chemically initiated skin tumors.
Mohanan S; Horibata S; Anguish LJ; Mukai C; Sams K; McElwee JL; McLean D; Yan A; Coonrod SA
Cell Tissue Res; 2017 Nov; 370(2):275-283. PubMed ID: 28766045
[TBL] [Abstract][Full Text] [Related]
18. Manganese superoxide dismutase is a p53-regulated gene that switches cancers between early and advanced stages.
Dhar SK; Tangpong J; Chaiswing L; Oberley TD; St Clair DK
Cancer Res; 2011 Nov; 71(21):6684-95. PubMed ID: 22009531
[TBL] [Abstract][Full Text] [Related]
19. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion.
Darwiche N; Ryscavage A; Perez-Lorenzo R; Wright L; Bae DS; Hennings H; Yuspa SH; Glick AB
Oncogene; 2007 Oct; 26(48):6885-95. PubMed ID: 17525749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]